Australie - anglais - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - sucroferric oxyhydroxide, quantity: 2500 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; neohesperidin-dihydrochalcone; magnesium stearate; flavour - velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (ckd) on dialysis.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - sucroferric oxyhydroxide, quantity: 2500 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; neohesperidin-dihydrochalcone; magnesium stearate; flavour - velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (ckd) on dialysis.

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - sucroferric oxyhydroxide -

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - sucroferric oxyhydroxide -

Union européenne - anglais - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - drugs for treatment of hyperkalemia and hyperphosphatemia - velphoro is indicated for the control of serum phosphorus levels in adult chronic kidney disease (ckd) patients on haemodialysis (hd) or peritoneal dialysis (pd).velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate

Israël - anglais - Ministry of Health

cts ltd - iron as sucroferric oxyhydroxide - chewable tablets - iron as sucroferric oxyhydroxide 500 mg - sucroferric oxyhydroxide - velphoro is indicated for the control of serum phosphorus levels in adult chronic kidney disease (ckd) patients on haemodialysis (hd) or peritoneal dialysis (pd).velphoro should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues, or calcimimetics to control the development of renal bone disease.

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

vifor fresenius medical care renal pharma uk ltd - sucroferric oxyhydroxide - chewable tablet - 500mg

États-Unis - anglais - NLM (National Library of Medicine)

fresenius medical care north america - ferric oxyhydroxide (unii: 87pzu03k0k) (ferric oxyhydroxide - unii:87pzu03k0k) - iron 500 mg - velphoro is indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. none. velphoro is not systemically absorbed following oral administration and maternal use is not expected to result in fetal exposure to the drug. data animal data in pregnant rats given up to 800 mg/kg/day velphoro by oral gavage from days 6 to 17 post-mating, no embryo-fetal development toxicity was observed. this dose corresponds to 16 times the maximum recommended clinical dose. in pregnant rabbits given 50, 100 or 200 mg/kg/day velphoro by oral gavage, from days 6 to 19 post-mating, the number of fetuses with incomplete/unossified epiphyses and metacarpals/phalanges was increased at the highest dose (corresponding to 4 times the recommended maximum clinical dose). litter parameters were not adversely affected. in pregnant rats given velphoro at 100, 280, or 800 mg/kg/day by oral gavage from day 6 post-mating to lactation day 20, offspring body weight gain was lower at age 5-13 weeks and

Canada - anglais - Health Canada

vifor fresenius medical care renal pharma ltd - iron (sucroferric oxyhydroxide) - tablet (chewable) - 500mg - iron (sucroferric oxyhydroxide) 500mg - phosphate-removing agents

Singapour - anglais - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - sucroferric oxyhydroxide 2,500mg eqv iron - tablet, chewable - sucroferric oxyhydroxide 2,500mg eqv iron 500 mg